New medication for treatment resistant depression added to PBS The nasal spray is available from 1 May to eligible patients, but a GP expert remains concerned about its accessibility.
Opioid agonist treatment prevents hundreds of suicides: Study Australian research predicts the treatment has prevented around 300 suicide deaths among NSW patients with opioid use disorder.
Changes coming to MBS telehealth regulations The changes, coming into effect from 1 November, will be tied to a patient’s registered MyMedicare practice.
Do GPs know enough about this ‘debilitating’ disorder? Experts agree there has been a dire lack of education around PMDD, but GPs could be in the ‘ideal situation’ to help.
New guide to support GPs ease cancer recurrence anxiety With 60% of patients anxious their cancer will return, the three-step clinical pathway is designed to offer practical and streamlined advice.
In Practice: Call for GPs to join dementia study New research aims to gather GPs’ understanding of and attitudes to dementia diagnosis and management, and the use of blood-based biomarkers.
Do IUDs cause breast cancer? Here’s what the evidence says A study has found a link between the devices and breast cancer, and while the research is important, it may be causing unnecessary worry.
Promising new treatment for incurable prostate cancer Groundbreaking Australian research has unveiled a promising new treatment for patients with aggressive and therapy-resistant cancer.
Federal Government reveals long-awaited Better Access response It says the mental health system is ‘difficult to navigate’, but supported less than half of the recommendations in full.
PBS additions for cancer and epilepsy Tens of thousands of patients each year are set to benefit from several first-time additions, including Zyamis and Tecentriq SC.